Andrea Everding

836 total citations
5 papers, 318 citations indexed

About

Andrea Everding is a scholar working on Rheumatology, Immunology and Genetics. According to data from OpenAlex, Andrea Everding has authored 5 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 3 papers in Immunology and 1 paper in Genetics. Recurrent topics in Andrea Everding's work include Rheumatoid Arthritis Research and Therapies (4 papers), Psoriasis: Treatment and Pathogenesis (2 papers) and Spondyloarthritis Studies and Treatments (2 papers). Andrea Everding is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Psoriasis: Treatment and Pathogenesis (2 papers) and Spondyloarthritis Studies and Treatments (2 papers). Andrea Everding collaborates with scholars based in United States, United Kingdom and Australia. Andrea Everding's co-authors include Alvina D. Chu, Désirée van der Heijde, Tae‐Hwan Kim, Aileen L. Pangan, Filip Van den Bosch, Atul Deodhar, Xin Wang, Walter P. Maksymowych, Mitsumasa Kishimoto and Joachim Sieper and has published in prestigious journals such as The Lancet, Annals of the Rheumatic Diseases and Arthritis Research & Therapy.

In The Last Decade

Andrea Everding

3 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea Everding United States	3	271	177	141	32	25	5	318
Peter Wung United States	6	236 0.9×	151 0.9×	121 0.9×	24 0.8×	23 0.9×	20	270
Yunxia Sui United States	7	368 1.4×	214 1.2×	181 1.3×	55 1.7×	37 1.5×	10	434
Timothy Gathany United States	7	273 1.0×	105 0.6×	129 0.9×	9 0.3×	25 1.0×	13	312
Roman Puliaev United States	11	122 0.5×	264 1.5×	56 0.4×	27 0.8×	9 0.4×	15	318
Graziella Carella Italy	8	72 0.3×	152 0.9×	52 0.4×	16 0.5×	27 1.1×	15	211
Jörg Lohmann Germany	7	98 0.4×	208 1.2×	60 0.4×	29 0.9×	14 0.6×	13	266
Karen Hambardzumyan Sweden	9	225 0.8×	63 0.4×	58 0.4×	22 0.7×	22 0.9×	15	282
Mark Coyne United Kingdom	5	86 0.3×	49 0.3×	39 0.3×	15 0.5×	22 0.9×	13	167
Pilar Perez Abellan United Kingdom	5	42 0.2×	157 0.9×	203 1.4×	49 1.5×	18 0.7×	8	309
Annika Wiedemann Germany	9	108 0.4×	193 1.1×	10 0.1×	44 1.4×	12 0.5×	19	252

Countries citing papers authored by Andrea Everding

Since Specialization

Citations

This map shows the geographic impact of Andrea Everding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Everding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Everding more than expected).

Fields of papers citing papers by Andrea Everding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Everding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Everding. The network helps show where Andrea Everding may publish in the future.

Co-authorship network of co-authors of Andrea Everding

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Everding. A scholar is included among the top collaborators of Andrea Everding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Everding. Andrea Everding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Buttgereit, Frank, Andrea Everding, Felipe Barreto Schuch, et al.. (2025). OP0058 Effects of clofutriben, a selective 11ß-hydroxysteroid dehydrogenase type 1 inhibitor, on efficacy and toxicity of prednisolone in patients with polymyalgia rheumatica. Annals of the Rheumatic Diseases. 84. 51–51.

2.

Genovese, Mark C., Juan Sánchez‐Bursón, Myungshin Oh, et al.. (2020). Comparative clinical efficacy and safety of the proposed biosimilar ABP 710 with infliximab reference product in patients with rheumatoid arthritis. Arthritis Research & Therapy. 22(1). 60–60. 15 indexed citations

3.

Heijde, Désirée van der, Aileen L. Pangan, Atul Deodhar, et al.. (2019). Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial. The Lancet. 394(10214). 2108–2117. 242 indexed citations

4.

Kivitz, Alan, Peter Nash, Hasan Tahir, et al.. (2019). Efficacy and Safety of Subcutaneous Secukinumab 150 mg with or Without Loading Regimen in Psoriatic Arthritis: Results from the FUTURE 4 Study. Rheumatology and Therapy. 6(3). 393–407. 61 indexed citations

5.

Hall, Stephen, Tsutomu Takeuchi, G. T. D. Thomson, et al.. (2019). THU0174 CHARACTERIZATION OF REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH UPADACITINIB OR COMPARATORS. Annals of the Rheumatic Diseases. 78. 362–362.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact